Welcome to our dedicated page for CROSS COUNTRY HEALTHCARE SEC filings (Ticker: CCRN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CROSS COUNTRY HEALTHCARE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CROSS COUNTRY HEALTHCARE's regulatory disclosures and financial reporting.
Clark Kevin Cronin reported acquisition or exercise transactions in this Form 4 filing.
Cross Country Healthcare Chief Executive Officer Kevin Cronin reported an award of 138,963 shares of restricted common stock at no purchase price. These shares vest in three substantially equal installments on March 31, 2027, March 31, 2028 and March 31, 2029.
Following the award, he holds 948,133 shares directly. A separate line reflects 3,961 shares held indirectly by his spouse, for which he disclaims beneficial ownership except for any pecuniary interest.
CROSS COUNTRY HEALTHCARE INC Chief Financial Officer William J. Burns reported routine equity compensation and related tax withholding transactions in company stock. He received a grant of 47,873 restricted shares of common stock at no cost, which vest in three substantially equal installments on March 31, 2027, March 31, 2028, and March 31, 2029.
To cover tax obligations on restricted stock that vested on March 31, 2026, 2,423 shares and 2,890 shares of common stock were withheld at a value of $9.40 per share. After these transactions, Burns directly holds 336,438 shares of CROSS COUNTRY HEALTHCARE INC common stock.
Cross Country Healthcare General Counsel Susan E. Ball reported routine equity compensation and related tax withholding transactions. On March 31, 2026, she received a grant of 33,644 shares of common stock at no cost, described as restricted shares that will vest in three substantially equal installments on March 31, 2027, March 31, 2028, and March 31, 2029.
On the same date, 1,689 and 2,014 shares were withheld at $9.40 per share to satisfy tax withholding obligations for restricted stock that vested on March 31, 2026. After these transactions, she directly holds 241,777 shares of Cross Country Healthcare common stock.
CROSS COUNTRY HEALTHCARE INC Chief Accounting Officer Marvin Veizaga reported equity compensation activity in company stock. He received a grant of 9,043 shares of common stock, described as restricted shares that vest in three substantially equal installments on March 31, 2027, March 31, 2028, and March 31, 2029. To cover tax withholding obligations for restricted stock that vested on March 31, 2026, 938 shares were withheld in two transactions at $9.40 per share. After these transactions and a correction for 4,471 previously omitted shares from an earlier Form 3, Veizaga directly holds 31,716 shares of common stock.
Cross Country Healthcare is asking stockholders to vote at its virtual 2026 Annual Meeting on May 11, 2026, including electing six directors, ratifying Deloitte & Touche as auditor, approving 2025 executive pay on an advisory basis, and amending the 2024 Omnibus Incentive Plan.
CEO Kevin Clark has returned with a mandate to restore growth after a terminated merger with Aya Healthcare that slowed 2025 momentum. The company highlights a debt‑free balance sheet and 2025 revenue of about $1.1 billion, Adjusted EBITDA of $26.8 million (2.5% margin), Adjusted EPS of $0.02, strong cash flow of $48.3 million, and repurchases of 0.8 million shares for $6.5 million.
The six‑member board is majority independent, with robust committee oversight of audit, compensation, governance, cybersecurity, environmental and climate risks, and artificial intelligence. Executive pay is heavily performance‑based; 2025 cash incentives paid out well below target and no performance shares were earned for the 2023–2025 cycle, while new 2025 equity awards were granted late in the year with multi‑year vesting and performance goals tied to cumulative Adjusted EBITDA and Adjusted EPS.
Cross Country Healthcare, Inc. reported that its Board of Directors appointed Amiee Hawkins as Chief Operating Officer, effective March 28, 2026. She previously served as Chief Solutions and Operations Officer and has held a series of senior operational roles since joining the company in 2014.
The company stated there were no new or amended agreements or changes to Ms. Hawkins’ compensation in connection with this appointment. It also disclosed that she has no family relationships with directors or executive officers and no material related-party transactions requiring disclosure.
Cross Country Healthcare Inc: The Vanguard Group filed an amended Schedule 13G/A reporting 0 shares beneficially owned and 0% of Common Stock. The amendment explains an internal realignment on January 12, 2026 and reliance on SEC Release No. 34-39538, with subsidiaries now reporting separately.
The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.
Cross Country Healthcare executive Marvin Veizaga, the Chief Accounting Officer, reported his initial beneficial ownership on a Form 3. He holds 19,140 shares of the company’s common stock directly following the reported position. The filing does not reflect any new purchase or sale, only existing holdings.